nature.com search

Loading Filters

Showing 1–49 of 49 results

Loading Filters

1 February 2007
Rituximab in CD20 positive multiple myeloma
- P Moreau
- , L Voillat
- , L Benboukher
- , C Mathiot
- , C Dumontet
- , N Robillard
- , O Hérault
- , F Garnache
- , R Garand
- , N Varoqueaux
- , H Avet-Loiseau
- , J L Harousseau
- & R Bataille
Leukemia 21 , 835–836

Rights & permissionsfor article Rituximab in CD20 positive multiple myeloma . Opens in a new window.
29 April 2010
Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005–01 trial
- P Moreau
- , C Hulin
- , G Marit
- , D Caillot
- , T Facon
- , P Lenain
- , C Berthou
- , B Pégourié
- , A M Stoppa
- , P Casassus
- , M Michallet
- , L Benboubker
- , H Maisonneuve
- , C Doyen
- , S Leyvraz
- , C Mathiot
- , H Avet-Loiseau
- , M Attal
- & J L Harousseau
Leukemia 24 , 1233–1235

Rights & permissionsfor article Stem cell collection in patients with <i>de novo</i> multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005–01 trial . Opens in a new window.
30 October 2008
Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases
- P Chevallier
- , N Robillard
- , G Houille
- , S Ayari
- , T Guillaume
- , J Delaunay
- , J-L Harousseau
- , H Avet-Loiseau
- , M Mohty
- & R Garand
Leukemia 23 , 806–807

Rights & permissionsfor article Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases . Opens in a new window.
22 October 2009
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin
- P Chevallier
- , T Prebet
- , A Pigneux
- , M Hunault
- , J Delaunay
- , F Perry
- , L Lode
- , S Richebourg
- , O Blanchet
- , N Vey
- , N Ifrah
- , N Milpied
- , D Blaise
- , J-L Harousseau
- & M Mohty
Leukemia 24 , 467–469

Rights & permissionsfor article Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin . Opens in a new window.
26 September 2003
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma
- R Garand
- , H Avet-Loiseau
- , F Accard
- , P Moreau
- , J L Harousseau
- & R Bataille
Leukemia 17 , 2032–2035

Rights & permissionsfor article t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma . Opens in a new window.
Amendments and Corrections | 25 April 2007
Erratum: International uniform response criteria for multiple myeloma
- B G M Durie
- , J-L Harousseau
- , J S Miguel
- , J Bladé
- , B Barlogie
- , K Anderson
- , M Gertz
- , M Dimopoulos
- , J Westin
- , P Sonneveld
- , H Ludwig
- , G Gahrton
- , M Beksac
- , J Crowley
- , A Belch
- , M Boccadaro
- , I Turesson
- , D Joshua
- , D Vesole
- , R Kyle
- , R Alexanian
- , G Tricot
- , M Attal
- , G Merlini
- , R Powles
- , P Richardson
- , K Shimizu
- , P Tosi
- , G Morgan
- & S V Rajkumar
Leukemia 21 , 1134–1134

Rights & permissionsfor article Erratum: International uniform response criteria for multiple myeloma . Opens in a new window.
Research | 5 March 1999
Epstein–Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation
- N Milpied
- , M Coste-Burel
- , F Accard
- , A Moreau
- , P Moreau
- , R Garand
- & J-L Harousseau
Bone Marrow Transplantation 23 , 629–630

Rights & permissionsfor article Epstein–Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation . Opens in a new window.
31 August 2009
Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors
- E Brissot
- , P Chevallier
- , T Guillaume
- , J Delaunay
- , S Ayari
- , V Dubruille
- , S Le Gouill
- , B Mahe
- , T Gastinne
- , N Blin
- , B Saulquin
- , P Moreau
- , J-L Harousseau
- & M Mohty
Bone Marrow Transplantation 45 , 786–788

Rights & permissionsfor article Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors . Opens in a new window.
23 March 2009
Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors
- E Brissot
- , P Chevallier
- , T Guillaume
- , J Delaunay
- , S Ayari
- , V Dubruille
- , S Le Gouill
- , B Mahe
- , T Gastinne
- , N Blin
- , B Saulquin
- , G Flandrois
- , A Devys
- , V Stocco
- , A Cesbron
- , F Dehaut
- , P Moreau
- , J-L Harousseau
- & M Mohty
Bone Marrow Transplantation 44 , 613–615

Rights & permissionsfor article Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors . Opens in a new window.
Amendments and Corrections | 22 November 2006
Erratum: International uniform response criteria for multiple myeloma
- B G M Durie
- , J-L Harousseau
- , J S Miguel
- , J Bladé
- , B Barlogie
- , K Anderson
- , M Gertz
- , M Dimopoulos
- , J Westin
- , P Sonneveld
- , H Ludwig
- , G Gahrton
- , M Beksac
- , J Crowley
- , A Belch
- , M Boccadaro
- , I Turesson
- , D Joshua
- , D Vesole
- , R Kyle
- , R Alexanian
- , G Tricot
- , M Attal
- , G Merlini
- , R Powles
- , P Richardson
- , K Shimizu
- , P Tosi
- & G Morgan
Leukemia 20 , 2220–2220

Rights & permissionsfor article Erratum: International uniform response criteria for multiple myeloma . Opens in a new window.
4 August 2008
Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens
- X Cahu
- , M Mohty
- , C Faucher
- , P Chevalier
- , N Vey
- , J El-Cheikh
- , T Guillaume
- , S Furst
- , J Delaunay
- , S Ayari
- , P Moreau
- , J A Gastaut
- , J L Harousseau
- & D Blaise
Bone Marrow Transplantation 42 , 689–691

Rights & permissionsfor article Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens . Opens in a new window.
15 February 2011
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma
- P Moreau
- , F Cavallo
- , X Leleu
- , C Hulin
- , M Amiot
- , G Descamps
- , T Facon
- , M Boccadoro
- , D Mignard
- & J L Harousseau
Leukemia 25 , 872–874

Rights & permissionsfor article Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma . Opens in a new window.
Research | 15 April 2014
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
- D Rossille
- , M Gressier
- , D Damotte
- , D Maucort-Boulch
- , C Pangault
- , G Semana
- , S Le Gouill
- , C Haioun
- , K Tarte
- , T Lamy
- , N Milpied
- , T Fest
- , G Damaj
- , A Clavert
- , A Al Jijakli
- , A Banos
- , J-L Dutel
- , E Deconinck
- , P Rodon
- , K Bouabdallah
- , P Soubeyran
- , B Choufi
- , A Maakaroun
- , O Tournilhac
- , J Fleury
- , R Gressin
- , H Maisonneuve
- , K Laribi
- , P Solal-Celigny
- , P Moreau
- , J-F Rossi
- , G Cartron
- , N Morineau
- , J L Harousseau
- , E Jourdan
- , M Alexis
- , F Dreyfus
- , V Delwail
- , J Cornillon
- , R Garidi
- , E Gyan
- , P Colombat
- & P Godemer
Leukemia 28 , 2367–2375

Rights & permissionsfor article High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial . Opens in a new window.
23 December 2011
Management of treatment-emergent peripheral neuropathy in multiple myeloma
- P G Richardson
- , M Delforge
- , M Beksac
- , P Wen
- , J L Jongen
- , O Sezer
- , E Terpos
- , N Munshi
- , A Palumbo
- , S V Rajkumar
- , J L Harousseau
- , P Moreau
- , H Avet-Loiseau
- , J H Lee
- , M Cavo
- , G Merlini
- , P Voorhees
- , W J Chng
- , A Mazumder
- , S Usmani
- , H Einsele
- , R Comenzo
- , R Orlowski
- , D Vesole
- , J J Lahuerta
- , R Niesvizky
- , D Siegel
- , M-V Mateos
- , M Dimopoulos
- , S Lonial
- , S Jagannath
- , J Bladé
- , J San Miguel
- , G Morgan
- , K C Anderson
- , B G M Durie
- & P Sonneveld
Leukemia 26 , 595–608

Rights & permissionsfor article Management of treatment-emergent peripheral neuropathy in multiple myeloma . Opens in a new window.
9 October 2013
Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia
- C Récher
- , M C Béné
- , B Lioure
- , A Pigneux
- , N Vey
- , J Delaunay
- , I Luquet
- , M Hunault
- , D Guyotat
- , D Bouscary
- , N Fegueux
- , E Jourdan
- , S Lissandre
- , M Escoffre-Barbe
- , C Bonmati
- , E Randriamalala
- , R Guièze
- , M Ojeda-Uribe
- , F Dreyfus
- , J L Harousseau
- , J Y Cahn
- , N Ifrah
- & P Guardiola
Leukemia 28 , 440–443

Rights & permissionsfor article Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia . Opens in a new window.
Research | 7 December 2015
Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution
- E Brissot
- , F Rialland
- , X Cahu
- , M Strullu
- , N Corradini
- , C Thomas
- , N Blin
- , X Rialland
- , E Thebaud
- , P Chevallier
- , P Moreau
- , N Milpied
- , J L Harousseau
- , F Mechinaud
- & M Mohty
Bone Marrow Transplantation 51 , 267–272

Rights & permissionsfor article Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution . Opens in a new window.
15 November 2007
Mature B-cell lymphoblastic leukemia with MLL rearrangement: an uncommon and distinct subset of childhood acute leukemia
- N Blin
- , F Méchinaud
- , P Talmant
- , R Garand
- , P Boutard
- , N Dastugue
- , E A McIntyre
- , J L Harousseau
- & H Avet-Loiseau
Leukemia 22 , 1056–1059

Rights & permissionsfor article Mature B-cell lymphoblastic leukemia with <i>MLL</i> rearrangement: an uncommon and distinct subset of childhood acute leukemia . Opens in a new window.
1 October 2007
The evolving background for high-dose treatment for myeloma
- B Sirohi
- , R Powles
- , J L Harousseau
- & K C Anderson
Bone Marrow Transplantation 40 , 1097–1100

Rights & permissionsfor article The evolving background for high-dose treatment for myeloma . Opens in a new window.
11 November 2004
Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma
- S Wuilleme
- , N Robillard
- , L Lodé
- , F Magrangeas
- , H Beris
- , J-L Harousseau
- , J Proffitt
- , S Minvielle
- & H Avet-Loiseau
Leukemia 19 , 275–278

Rights & permissionsfor article Ploidy, as detected by fluorescence <i>in situ</i> hybridization, defines different subgroups in multiple myeloma . Opens in a new window.
28 February 2011
New developments in conditioning regimens before auto-SCT in multiple myeloma
- P Moreau
- , M Attal
- & J L Harousseau
Bone Marrow Transplantation 46 , 911–915

Rights & permissionsfor article New developments in conditioning regimens before auto-SCT in multiple myeloma . Opens in a new window.
Research | 28 March 2003
PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma
- B Mahé
- , N Milpied
- , M P Mellerin
- , P Moreau
- , N Morineau
- , M Vigier
- & J L Harousseau
Bone Marrow Transplantation 31 , 467–473

Rights & permissionsfor article PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma . Opens in a new window.
Research | 25 May 1999
Melphalan 220 mg/m² followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma
- P Moreau
- , N Milpied
- , B Mahé
- , N Juge-Morineau
- , M-J Rapp
- , R Bataille
- & J-L Harousseau
Bone Marrow Transplantation 23 , 1003–1006

Rights & permissionsfor article Melphalan 220 mg/m<sup>2</sup> followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma . Opens in a new window.
Research | 25 February 2011
Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation
- Z Peric
- , X Cahu
- , P Chevallier
- , E Brissot
- , F Malard
- , T Guillaume
- , J Delaunay
- , S Ayari
- , V Dubruille
- , S Le Gouill
- , B Mahe
- , T Gastinne
- , N Blin
- , B Saulquin
- , J-L Harousseau
- , P Moreau
- , N Milpied
- , M Coste-Burel
- , B-M Imbert-Marcille
- & M Mohty
Leukemia 25 , 932–938

Rights & permissionsfor article Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation . Opens in a new window.
Research | 12 July 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
- P Moreau
- , M Attal
- , F Garban
- , C Hulin
- , T Facon
- , G Marit
- , M Michallet
- , C Doyen
- , S Leyvraz
- , M Mohty
- , M Wetterwald
- , C Mathiot
- , D Caillot
- , C Berthou
- , L Benboubker
- , L Garderet
- , C Chaleteix
- , C Traullé
- , J G Fuzibet
- , J Jaubert
- , T Lamy
- , P Casassus
- , M Dib
- , B Kolb
- , V Dorvaux
- , B Grosbois
- , I Yakoub-Agha
- , J L Harousseau
- & H Avet-Loiseau
Leukemia 21 , 2020–2024

Rights & permissionsfor article Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials . Opens in a new window.
8 December 1998
The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
- C Pellat-Deceunynck
- , S Barillé
- , G Jego
- , D Puthier
- , N Robillard
- , D Pineau
- , M-J Rapp
- , J-L Harousseau
- , M Amiot
- & R Bataille
Leukemia 12 , 1977–1982

Rights & permissionsfor article The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma . Opens in a new window.
Research | 31 May 2010
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [¹⁸F] FDG-PET diffuse large B-cell lymphoma patients
- V Roland
- , C Bodet-Milin
- , A Moreau
- , T Gastinne
- , B Mahé
- , V Dubruille
- , H Maisonneuve
- , N Juge-Morineau
- , P Moreau
- , H Jardel
- , L Planche
- , M Mohty
- , P Moreau
- , J-L Harousseau
- , F Kraeber-Bodéré
- & S Le Gouill
Bone Marrow Transplantation 46 , 393–399

Rights & permissionsfor article Impact of high-dose chemotherapy followed by auto-SCT for positive interim [<sup>18</sup>F] FDG-PET diffuse large B-cell lymphoma patients . Opens in a new window.
27 May 2010
Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial
- P Chevallier
- , L Fornecker
- , B Lioure
- , M C Béné
- , A Pigneux
- , C Recher
- , B Witz
- , N Fegueux
- , C-E Bulabois
- , S Daliphard
- , D Bouscary
- , N Vey
- , M Delain
- , J-O Bay
- , P Turlure
- , M Bernard
- , C Himberlin
- , I Luquet
- , N Ifrah
- & J-L Harousseau
Leukemia 24 , 1380–1385

Rights & permissionsfor article Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial . Opens in a new window.
2 August 2005 | Open
Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours
- U De Giorgi
- , G Rosti
- , S Slavin
- , I Yaniv
- , J L Harousseau
- , R Ladenstein
- , T Demirer
- & G Dini
British Journal of Cancer 93 , 412–417

Rights & permissionsfor article Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours . Opens in a new window.
Research | 6 July 2009
Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation
- P Chevallier
- , T Prebet
- , P Turlure
- , M Hunault
- , S Vigouroux
- , J-L Harousseau
- , D Blaise
- , N Ifrah
- , N Milpied
- & M Mohty
Bone Marrow Transplantation 45 , 165–170

Rights & permissionsfor article Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation . Opens in a new window.
30 August 2002
Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells
- S Le Gouill
- , C Pellat-Deceunynck
- , J-L Harousseau
- , M-J Rapp
- , N Robillard
- , R Bataille
- & M Amiot
Leukemia 16 , 1664–1667

Rights & permissionsfor article Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells . Opens in a new window.
20 July 2006
International uniform response criteria for multiple myeloma
- B G M Durie
- , J-L Harousseau
- , J S Miguel
- , J Bladé
- , B Barlogie
- , K Anderson
- , M Gertz
- , M Dimopoulos
- , J Westin
- , P Sonneveld
- , H Ludwig
- , G Gahrton
- , M Beksac
- , J Crowley
- , A Belch
- , M Boccadaro
- , I Turesson
- , D Joshua
- , D Vesole
- , R Kyle
- , R Alexanian
- , G Tricot
- , M Attal
- , G Merlini
- , R Powles
- , P Richardson
- , K Shimizu
- , P Tosi
- , G Morgan
- & S V Rajkumar
Leukemia 20 , 1467–1473

Rights & permissionsfor article International uniform response criteria for multiple myeloma . Opens in a new window.
Research | 13 June 2012 | Open
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients
- A Bradwell
- , S Harding
- , N Fourrier
- , C Mathiot
- , M Attal
- , P Moreau
- , J-L Harousseau
- & H Avet-Loiseau
Leukemia 27 , 202–207

Rights & permissionsfor article Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients . Opens in a new window.
3 January 2003
Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients
- F Maloisel
- , L Benboubker
- , M Gardembas
- , B Coiffier
- , M Divine
- , C Sebban
- , M Blanc
- , J-F Abgrall
- , P Lederlin
- , J-L Harousseau
- , A-M Blaise
- , B Grosbois
- , P Morice
- , C Ghandour
- & S Castaigne
Leukemia 17 , 45–51

Rights & permissionsfor article Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients . Opens in a new window.
Research | 17 January 2008
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study
- J F San-Miguel
- , P G Richardson
- , P Sonneveld
- , M W Schuster
- , D Irwin
- , E A Stadtmauer
- , T Facon
- , J-L Harousseau
- , D Ben-Yehuda
- , S Lonial
- , H Goldschmidt
- , D Reece
- , J Bladé
- , M Boccadoro
- , J D Cavenagh
- , R Neuwirth
- , A L Boral
- , D-L Esseltine
- & K C Anderson
Leukemia 22 , 842–849

Rights & permissionsfor article Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study . Opens in a new window.
Research | 18 February 2011
A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study
- P Chevallier
- , M Labopin
- , P Turlure
- , T Prebet
- , A Pigneux
- , M Hunault
- , K Filanovsky
- , P Cornillet-Lefebvre
- , I Luquet
- , L Lode
- , S Richebourg
- , O Blanchet
- , N Gachard
- , N Vey
- , N Ifrah
- , N Milpied
- , J-L Harousseau
- , M-C Bene
- , M Mohty
- & J Delaunay
Leukemia 25 , 939–944

Rights & permissionsfor article A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study . Opens in a new window.
5 February 1999
Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy
- D Puthier
- , C Pellat-Deceunynck
- , S Barillé
- , N Robillard
- , M-J Rapp
- , N Juge-Morineau
- , J-L Harousseau
- , R Bataille
- & M Amiot
Leukemia 13 , 289–294

Rights & permissionsfor article Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy . Opens in a new window.
25 February 2010
JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5
- C Cleyrat
- , J Jelinek
- , F Girodon
- , M Boissinot
- , T Ponge
- , J-L Harousseau
- , J-P Issa
- & S Hermouet
Leukemia 24 , 1069–1073

Rights & permissionsfor article JAK2 mutation and disease phenotype: a double L611V/V617F <i>in cis</i> mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5 . Opens in a new window.
7 October 1999
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients
- R Bouabdallah
- , F Lefrère
- , C Rose
- , P Chaïbi
- , J-L Harousseau
- , J-P Vernant
- , S Castaigne
- , F Bauduer
- , J-M Zini
- , D Coso
- , B Varet
- , J Robert
- & P Fenaux
Leukemia 13 , 1491–1496

Rights & permissionsfor article A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients . Opens in a new window.
Research | 1 June 1986
High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease
- T Philip
- , J Dumont
- , F Teillet
- , D Maraninchi
- , N C Gorin
- , M Kuentz
- , J L Harousseau
- , M Marty
- , R Pinkerton
- & P Herve
British Journal of Cancer 53 , 737–742

Rights & permissionsfor article High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease . Opens in a new window.
Research | 28 March 2011
Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation
- Z Peric
- , X Cahu
- , P Chevallier
- , E Brissot
- , F Malard
- , T Guillaume
- , J Delaunay
- , S Ayari
- , V Dubruille
- , S Le Gouill
- , B Mahé
- , T Gastinne
- , N Blin
- , B Saulquin
- , J-L Harousseau
- , P Moreau
- , M Coste-Burel
- , B-M Imbert-Marcille
- & M Mohty
Bone Marrow Transplantation 47 , 251–257

Rights & permissionsfor article Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation . Opens in a new window.
6 August 2007
The allogeneic dilemma
- J-L Harousseau
Bone Marrow Transplantation 40 , 1123–1128

Rights & permissionsfor article The allogeneic dilemma . Opens in a new window.
Research | 6 April 2009
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT
- P Chevallier
- , M Labopin
- , A Nagler
- , P Ljungman
- , L F Verdonck
- , L Volin
- , A R Zander
- , J Finke
- , G Socie
- , C Cordonnier
- , J-L Harousseau
- , M Mohty
- & V Rocha
Bone Marrow Transplantation 44 , 589–594

Rights & permissionsfor article Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT . Opens in a new window.
Research | 9 November 2006
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials
- S Jagannath
- , P G Richardson
- , P Sonneveld
- , M W Schuster
- , D Irwin
- , E A Stadtmauer
- , T Facon
- , J-L Harousseau
- , J M Cowan
- & K C Anderson
Leukemia 21 , 151–157

Rights & permissionsfor article Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials . Opens in a new window.
5 May 2005
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival
- S Wuillème-Toumi
- , N Robillard
- , P Gomez
- , P Moreau
- , S Le Gouill
- , H Avet-Loiseau
- , J-L Harousseau
- , M Amiot
- & R Bataille
Leukemia 19 , 1248–1252

Rights & permissionsfor article Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival . Opens in a new window.
20 November 2008
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
- A Dispenzieri
- , R Kyle
- , G Merlini
- , J S Miguel
- , H Ludwig
- , R Hajek
- , A Palumbo
- , S Jagannath
- , J Blade
- , S Lonial
- , M Dimopoulos
- , R Comenzo
- , H Einsele
- , B Barlogie
- , K Anderson
- , M Gertz
- , J L Harousseau
- , M Attal
- , P Tosi
- , P Sonneveld
- , M Boccadoro
- , G Morgan
- , P Richardson
- , O Sezer
- , M V Mateos
- , M Cavo
- , D Joshua
- , I Turesson
- , W Chen
- , K Shimizu
- , R Powles
- , S V Rajkumar
- & B G M Durie
Leukemia 23 , 215–224

Rights & permissionsfor article International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders . Opens in a new window.
2 September 2010
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group
- E Terpos
- , M A Dimopoulos
- , O Sezer
- , D Roodman
- , N Abildgaard
- , R Vescio
- , P Tosi
- , R Garcia-Sanz
- , F Davies
- , A Chanan-Khan
- , A Palumbo
- , P Sonneveld
- , M T Drake
- , J-L Harousseau
- , K C Anderson
- & B G M Durie
Leukemia 24 , 1700–1712

Rights & permissionsfor article The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group . Opens in a new window.
4 February 2011
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
- M A Dimopoulos
- , A Palumbo
- , M Attal
- , M Beksaç
- , F E Davies
- , M Delforge
- , H Einsele
- , R Hajek
- , J-L Harousseau
- , F Leal da Costa
- , H Ludwig
- , U-H Mellqvist
- , G J Morgan
- , J F San-Miguel
- , S Zweegman
- & P Sonneveld
Leukemia 25 , 749–760

Rights & permissionsfor article Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement . Opens in a new window.
Research | 23 July 2007
A pivotal role for Mcl-1 in Bortezomib-induced apoptosis
- K Podar
- , S L Gouill
- , J Zhang
- , J T Opferman
- , E Zorn
- , Y-T Tai
- , T Hideshima
- , M Amiot
- , D Chauhan
- , J-L Harousseau
- & K C Anderson
Oncogene 27 , 721–731

Rights & permissionsfor article A pivotal role for Mcl-1 in Bortezomib-induced apoptosis . Opens in a new window.
Research | 25 June 2009
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
- S Giralt
- , E A Stadtmauer
- , J L Harousseau
- , A Palumbo
- , W Bensinger
- , R L Comenzo
- , S Kumar
- , N C Munshi
- , A Dispenzieri
- , R Kyle
- , G Merlini
- , J San Miguel
- , H Ludwig
- , R Hajek
- , S Jagannath
- , J Blade
- , S Lonial
- , M A Dimopoulos
- , H Einsele
- , B Barlogie
- , K C Anderson
- , M Gertz
- , M Attal
- , P Tosi
- , P Sonneveld
- , M Boccadoro
- , G Morgan
- , O Sezer
- , M V Mateos
- , M Cavo
- , D Joshua
- , I Turesson
- , W Chen
- , K Shimizu
- , R Powles
- , P G Richardson
- , R Niesvizky
- , S V Rajkumar
- & B G M Durie
Leukemia 23 , 1904–1912

Rights & permissionsfor article International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100) . Opens in a new window.

Quick links